The global brain monitoring market size was pegged at $3.85 billion and is projected to reach $6.68 billion by 2026, registering CAGR of 6.8% during the period 2019–2026.
Rise in prevalence of neurological disorders, rapid technological advancements, and increase in geriatric population that is vulnerable to various brain injuries and other disorders have boosted the growth of the global brain monitoring market. However, stringent government regulations and unfavorable reimbursement policies hamper market growth. On the contrary, lucrative opportunities in the untapped market in developing countries are expected to propel the market growth.
Electroencephalography (EEG) devices segment held the lion's share
The EEG segment held the largest share in 2017, contributing about one-fifth of the total market share, owing to rise in demand for advanced imaging techniques, increase in investments by device manufacturers, and surge in demand for diagnosis of critical disorders such as epilepsy. However, the electromyography (EMG) devices segment is expected to manifest the fastest CAGR of 8.0% during the forecast period.
The report also includes other segments such as magnetoencephalography (MEG) devices, transcranial Doppler (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, sleep monitoring devices, accessories, and others.
Non-invasive procedures segment to manifest fastest growth by 2026
The non-invasive procedures segment is projected to portray the fastest CAGR of 6.9% during the study period. Moreover, the segment held the largest share, contributing about 90% of the total market in 2017. The report analyzes the segment of invasive procedure.
Traumatic brain injuries segment dominates the market
The traumatic brain injuries segment dominated the market in terms of market share, contributing about one-fifth of the total market in 2017. However, Parkinson's disease segment is estimated to portray the fastest CAGR of 8.8% during the forecast period. The report includes other segments such as epilepsy, dementia, Huntington's disease, headache disorders, stroke, sleep disorders, and other diseases.
Asia-Pacific region to portray fastest CAGR through 2026
Asia-Pacific region is projected manifest the fastest CAGR of 9.2% during the forecast period, owing to increase in awareness regarding the importance of predictive analytics and large number of R&D activities for the development of predictive analytics tools in the developing regions. However, North America region held the largest share, contributing more than two-fifths of the market share in 2017, owing to high adoption rate of predictive analytics software and well-established healthcare infrastructure. The report includes analysis of other regions such as Europe and Latin America, Middle East and Africa (LAMEA).
The report analyzes and forecasts the brain monitoring market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global brain monitoring market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the brain monitoring market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of brain monitoring market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Competitive Landscape is the most valuable part of this report
The report profiles the major companies in the market, including Advanced Brain Monitoring, Inc., Compumedics Ltd., Koninklijke Philips N.V. (Philips Healthcare), Natus Medical Incorporated, Siemens AG, CAS Medical Systems, Inc., General Electric Company (GE Healthcare), Medtronic Plc., and Neural Analytics, Inc.
Key financial developments of a particular company and product & company overview are some of the elements that help in acquiring information about top vendors in the market. This particular section has also included a SWOT analysis of the companies featured in the report. This will help the audience in knowing about opportunities, strengths, threats and weaknesses that are facing by the key vendors in the chemical and material industry across the world. As the competitive landscape is the most valuable part of any report, it consists of all the required information for the detailed study of top players functioning in the industries. It is also an interesting part to find how exactly these key manufacturers implement various strategies to secure the top rank in the industry. Such an in-depth information is useful for the new entrants into the industry as they would be able to learn a bit from these key vendors. Similarly, the information provided in the research report will also be valuable for the renowned key players as well, as they come to know the strategies of their counterparts to sustain in the competitive industry.
Segmentation:
Product Type
By Procedure
By Application
By Region
Report coverage
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Section 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Section 2: EXECUTIVE SUMMARY
2.1. CXO perspective
Section 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the geriatric population
3.4.1.2. Increase in prevalence of neurological disorders
3.4.1.3. Technological advancements
3.4.2. Restraints
3.4.2.1. Stringent government regulations
3.4.2.2. Unfavorable reimbursement policies
3.4.3. Opportunity
3.4.3.1. Untapped markets in developing countries
Section 4: BRAIN MONITORING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Electroencephalography devices (EEG)
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Magnetoencephalography devices (MEG)
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Transcranial Doppler devices (TCD)
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Intracranial pressure monitors (ICP)
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Cerebral oximeters
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Electromyography devices
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. Magnetic resonance imaging devices (MRI)
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country
4.9. Computerized tomography devices (CT)
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast
4.9.3. Market analysis, by country
4.10. Positron emission tomography devices (PET)
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast
4.10.3. Market analysis, by country
4.11. Sleep monitoring devices
4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast
4.11.3. Market analysis, by country
4.12. Accessories
4.12.1. Key market trends, growth factors, and opportunities
4.12.1.1. Electrodes
4.12.1.2. Sensors
4.12.1.3. Paste & Gels
4.12.1.4. Caps
4.12.1.5. Cables
4.12.1.6. Batteries
4.12.1.7. Others
4.12.2. Market size and forecast, by region
4.12.3. Market analysis, by country
4.13. Other brain monitoring devices
4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast
4.13.3. Market analysis, by country
Section 5: BRAIN MONITORING MARKET, BY PROCEDURE
5.1. Overview
5.1.1. Market size and forecast
5.2. Invasive
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Non-invasive
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
Section 6: BRAIN MONITORING MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Epilepsy
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Dementia
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Parkinson’s Disease
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Huntington's Disease
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
6.6. Headache Disorders
6.6.1. Market size and forecast
6.6.2. Market analysis, by country
6.7. Stroke
6.7.1. Market size and forecast
6.7.2. Market analysis, by country
6.8. Traumatic Brain Injuries
6.8.1. Market size and forecast
6.8.2. Market analysis, by country
6.9. Sleep Disorders
6.9.1. Market size and forecast
6.9.2. Market analysis, by country
6.10. Other Diseases
6.10.1. Market size and forecast
6.10.2. Market analysis, by country
Section 7: BRAIN MONITORING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by product type
7.2.3. Market size and forecast, by procedure
7.2.4. Market size and forecast, by application
7.2.5. North America market size and forecast, by country
7.2.5.1. U.S. market size and forecast, by product type
7.2.5.2. U.S. market size and forecast, by procedure
7.2.5.3. U.S. market size and forecast, by application
7.2.5.4. Canada market size and forecast, by product type
7.2.5.5. Canada market size and forecast, by procedure
7.2.5.6. Canada market size and forecast, by application
7.2.5.7. Mexico market size and forecast, by product type
7.2.5.8. Mexico market size and forecast, by procedure
7.2.5.9. Mexico market size and forecast, by application
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by product type
7.3.3. Market size and forecast, by procedure
7.3.4. Market size and forecast, by application
7.3.5. Europe market size and forecast, by country
7.3.5.1. Germany market size and forecast, by product type
7.3.5.2. Germany market size and forecast, by procedure
7.3.5.3. Germany market size and forecast, by application
7.3.5.4. France market size and forecast, by product type
7.3.5.5. France market size and forecast, by procedure
7.3.5.6. France market size and forecast, by application
7.3.5.7. UK market size and forecast, by product type
7.3.5.8. UK market size and forecast, by procedure
7.3.5.9. UK market size and forecast, by application
7.3.5.10. Italy market size and forecast, by product type
7.3.5.11. Italy market size and forecast, by procedure
7.3.5.12. Italy market size and forecast, by application
7.3.5.13. Spain market size and forecast, by product type
7.3.5.14. Spain market size and forecast, by procedure
7.3.5.15. Spain market size and forecast, by application
7.3.5.16. Rest of Europe market size and forecast, by product type
7.3.5.17. Rest of Europe market size and forecast, by procedure
7.3.5.18. Rest of Europe market size and forecast, by application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by product type
7.4.3. Market size and forecast, by procedure
7.4.4. Market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by country
7.4.5.1. Japan market size and forecast, by product type
7.4.5.2. Japan market size and forecast, by procedure
7.4.5.3. Japan market size and forecast, by application
7.4.5.4. China market size and forecast, by product type
7.4.5.5. China market size and forecast, by procedure
7.4.5.6. China market size and forecast, by application
7.4.5.7. Australia market size and forecast, by product type
7.4.5.8. Australia market size and forecast, by procedure
7.4.5.9. Australia market size and forecast, by application
7.4.5.10. India market size and forecast, by product type
7.4.5.11. India market size and forecast, by procedure
7.4.5.12. India market size and forecast, by application
7.4.5.13. Rest of Asia-Pacific market size and forecast, by product type
7.4.5.14. Rest of Asia-Pacific market size and forecast, by procedure
7.4.5.15. Rest of Asia-Pacific market size and forecast, by application
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by product type
7.5.3. Market size and forecast, by procedure
7.5.4. Market size and forecast, by application
7.5.5. LAMEA market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by product type
7.5.5.2. Brazil market size and forecast, by procedure
7.5.5.3. Brazil market size and forecast, by application
7.5.5.4. Saudi Arabia market size and forecast, by product type
7.5.5.5. Saudi Arabia market size and forecast, by procedure
7.5.5.6. Saudi Arabia market size and forecast, by application
7.5.5.7. South Africa market size and forecast, by product type
7.5.5.8. South Africa market size and forecast, by procedure
7.5.5.9. South Africa market size and forecast, by application
7.5.5.10. Rest of LAMEA market size and forecast, by product type
7.5.5.11. Rest of LAMEA market size and forecast, by procedure
7.5.5.12. Rest of LAMEA market size and forecast, by application
Section 8: COMPANY PROFILES
8.1. ADVANCED BRAIN MONITORING, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.2. CAS MEDICAL SYSTEMS, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio
8.2.4. Business performance
8.3. COMPUMEDICS LTD.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product Portfolio
8.3.5. Business performance
8.4. GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. MEDTRONIC PLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. NATUS MEDICAL INCORPORATED
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. NEURAL ANALYTICS, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. NIHON KOHDEN CORPORATION
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. SIEMENS AG
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers